Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-05

Clinical Trial Update: Suubi4PrEP: Improving PrEP Access and Adherence Among Adolescent Girls and Young Women in Uganda [NA]

View source ↗

Summary

A clinical trial update for Suubi4PrEP in Uganda focusing on improving access and adherence to PrEP among adolescent girls and young women; currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Truvada (emtricitabine/tenofovir disoproxil fumarate) (emtricitabine/tenofovir disoproxil fumarate)

Snippet

Sponsor: Washington University School of Medicine | Conditions: HIV Prevention | NA | Status: RECRUITING